TABLE 3. Changes in the number and percentage of opioid deaths co-occurring with benzodiazepines, cocaine, and methamphetamine, by type of opioids involved in death — 25 states,* State Unintentional Drug Overdose Reporting System (SUDORS), July–December 2017 to January–June 2018.
Type of opioid involved in death | No. of opioid deaths with co-occurring drugs (%) |
|||
---|---|---|---|---|
Benzodiazepines† | Cocaine† | Methamphetamine† | None of the three drugs | |
All opioids§
|
−264 (−5.7)¶
|
−106 (−2.3)
|
206 (14.6)¶
|
−437 (−8.0)¶
|
Any IMF** |
256 (11.3)¶ |
445 (14.0)¶ |
241 (31.0)¶ |
217 (6.7)¶ |
Illicit opioid, no IMF†† |
−389 (−39.0)¶ |
−514 (−42.9)¶ |
−69 (−14.7)¶ |
−537 (−43.3)¶ |
Prescription opioid, no illicit opioid§§ | −131 (−9.7)¶ | −37 (−12.2) | 34 (20.5) | −117 (−12.0)¶ |
Abbreviation: IMF = illicitly manufactured fentanyl.
* Alaska, Connecticut, Delaware, Florida, Georgia, Illinois, Kentucky, Maine, Massachusetts, Minnesota, Missouri, Nevada, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Utah, Vermont, Virginia, Washington, and Wisconsin.
† Opioid deaths co-occurring with benzodiazepines, cocaine and methamphetamine are not mutually exclusive as deaths associated with multiple nonopioids (e.g., cocaine and benzodiazepines) will be counted in both categories.
§ All opioid deaths (N = 13,415 during January–June 2018).
¶ Statistically significant change from July–December 2017 to January–June 2018 based on z-tests or nonoverlapping confidence intervals if the number of deaths was <100 (p<0.05).
** All opioid deaths where IMF was involved (N = 9,105 during January–June 2018).
†† All deaths involving other illicit opioids (heroin, fentanyl analogs, and U-series) where IMF was not involved (N = 2,019 during January–June 2018).
§§ Deaths involving prescription opioids without illicit opioid involvement (N = 2,291 deaths during January–June 2018).